SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-008512
Filing Date
2024-05-21
Accepted
2024-05-21 08:30:14
Documents
13
Period of Report
2024-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20240515x8k.htm   iXBRL 8-K 34821
  Complete submission text file 0001558370-24-008512.txt   144383

Data Files

Seq Description Document Type Size
2 EX-101.SCH agrx-20240515.xsd EX-101.SCH 3435
3 EX-101.LAB agrx-20240515_lab.xml EX-101.LAB 14107
4 EX-101.PRE agrx-20240515_pre.xml EX-101.PRE 9014
16 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20240515x8k_htm.xml XML 4312
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 24966915
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)